Lab automation is defined as the use of technology to streamline or substitute manual
manipulation of equipment and processes. The degree of automation that any lab requires
depends on its workflow. While an academic research lab may prefer to use only some
instruments in order to increase productivity and reduce the time spent on a tedious task, a
drug discovery unit in a pharmaceutical company will perhaps need to automate all of its
research phases.
What the global Lab Automation Market Looks Like?
The global lab automation market is expected to reach USD 5.20 billion by 2022 from USD 4.06
billion in 2017, at a CAGR of 5.1%. Factors such as process miniaturization, high demand for lab
automation equipment in drug discovery and clinical diagnostics, higher reproducibility and
accuracy, and large workforce demand and supply gap are likely to drive the growth of this
market. In addition, lab automation offers enhanced productivity and reduced costs, better
personnel safety, and small volumes of samples and reagents. However, high cost is limiting the
adoption of lab automation among small and medium-sized labs which is likely to restrict the
market growth.
Segmentation Of Global Lab Automation Market:
In this report, the market is segmented on the basis of equipment and software, application,
end user, and region. On the basis of equipment and software, the lab automation market is
segmented into automated workstations, off-the-shelf workcells, robotic systems, automated
storage and retrieval system, software, and other equipment. The software segment is
projected to grow at the fastest rate owing to the rising need for efficient data storage,
analysis, and sharing methods.
Based on application, the market is segmented into drug discovery, clinical diagnostics,
genomics solutions, proteomics solutions, microbiology, and other applications. The drug
discovery segment is expected dominate the market in 2017. Lab automation eliminates human
errors involved in drug discovery and reduces the time-to-market for drugs, thus driving its
higher uptake in drug discovery. It also eliminates the need for many manual operations and
makes it viable to work with minute volumes of samples and reagents.
Based on end user, the lab automation market is segmented into biotechnology &
pharmaceutical companies, hospitals and diagnostic labs, and research & institutes. The
biotechnology & pharmaceutical companies segment is estimated to grow at the highest CAGR
during the forecast period. Factors such as increasing product intricacy, pricing pressure, high
cost incurred by errors, and need for consistency in quality are driving biotechnology and
pharmaceutical companies to adopt automation and accelerate the drug discovery process.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1158